Literature DB >> 26810858

Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy.

John P Bois1, Jonathon C Adams1, Gautam Kumar1, Steve R Ommen1, Rick A Nishimura1, Kyle W Klarich2.   

Abstract

Warm temperatures induce peripheral vasodilation, decrease afterload, and may concurrently increase the left ventricular outflow tract (LVOT) gradient. We aimed to assess the impact of subjective ambient temperature on hypertrophic cardiomyopathy (HC) symptoms and determine whether they were associated with LVOT gradient, patient quality of life (QOL), and risk of sudden cardiac death (SCD). We identified consecutive patients with HC presenting to a tertiary referral center. Of the 173 patients in the study, 143 (83%) had HC symptoms, with ambient temperature change worsening symptoms for 72 patients (50%). Symptom exacerbation occurred only with heat for 57 (79%), whereas symptoms were exacerbated with cold only or with cold and heat equally for 15 (21%). Patients affected by any temperature exacerbation more commonly were women (p = 0.009), had a lower QOL (p = 0.04), had a family history of HC (p = 0.007), or underwent myectomy (p = 0.01). A greater proportion of patients with heat-only exacerbation had a family history of HC (p = 0.005) and SCD (p = 0.05). The presence of an LVOT gradient either at rest or with provocation was similar in all groups. In conclusion, although no appreciable difference in LVOT gradients were observed between patient groups, approximately half of the patients with HC reporting symptoms at baseline noted worsening of symptoms with temperature changes, with >75% describing heat-induced symptom exacerbation. Furthermore, affected patients more frequently were women, underwent surgical intervention and device implantation, and had an overall lower QOL.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26810858      PMCID: PMC4775308          DOI: 10.1016/j.amjcard.2015.12.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Sympathetic stimulation and arrhythmias.

Authors:  D P Zipes
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

2.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

Authors:  Constantinos O'Mahony; Fatima Jichi; Menelaos Pavlou; Lorenzo Monserrat; Aristides Anastasakis; Claudio Rapezzi; Elena Biagini; Juan Ramon Gimeno; Giuseppe Limongelli; William J McKenna; Rumana Z Omar; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-10-14       Impact factor: 29.983

3.  Reflex cutaneous vasoconstriction during cold pressor test is mediated through alpha-adrenoceptors.

Authors:  S M Frank; S N Raja
Journal:  Clin Auton Res       Date:  1994-10       Impact factor: 4.435

4.  Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men.

Authors:  Demetra D Christou; Pamela Parker Jones; Jens Jordan; André Diedrich; David Robertson; Douglas R Seals
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

5.  Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Martin S Maron; A Selcuk Adabag; Susan A Casey; Daniela Vargiu; Mark S Link; James E Udelson; Franco Cecchi; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

6.  A qualitative validation of the Minnesota Living with Heart Failure Questionnaire.

Authors:  Tony Hak; Dick Willems; Gerrit van der Wal; Frans Visser
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

7.  Blood pressure response to thermoregulatory vasoconstriction during isoflurane and desflurane anesthesia.

Authors:  R Greif; S Laciny; A Rajek; A G Doufas; D I Sessler
Journal:  Acta Anaesthesiol Scand       Date:  2003-08       Impact factor: 2.105

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 9.  Measurement of health-related quality of life in heart failure.

Authors:  G H Guyatt
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

Review 10.  Temperature monitoring and perioperative thermoregulation.

Authors:  Daniel I Sessler
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

View more
  1 in total

1.  Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life.

Authors:  Erica Zaiser; Amy J Sehnert; Ashley Duenas; Sara Saberi; Ella Brookes; Matthew Reaney
Journal:  J Patient Rep Outcomes       Date:  2020-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.